Trending Health

In this episode of Trending Health, we explore how the Inflation Reduction Act (IRA) is reshaping strategy across the life sciences industry. Mindy McGrath is joined by Inizio Ignite colleagues, Scott Briggs and Ethan Johnson, to discuss how manufacturers are responding to Medicare price negotiation, Part D redesign, and increasing pressures on pricing and access. The conversation highlights what has surprised leaders so far, how payer dynamics are evolving, and how companies are rethinking po

The brain health economy is emerging as a critical focus across healthcare and policy both for treating serious neurological and mental health diseases and for increasing brain capital for society. In this episode, Inizio Ignite’s Varun Renjen sits down with George Vradenburg, Chairman of the Davos Alzheimer\’s Collaborative and Harris Eyre, Executive Director of the Global Brain Economy Initiative to explore why it’s evolving so rapidly and what it means for life sciences companies. From how t

In this news episode of Trending Health, Mindy McGrath and Everly Petruzzelli break down the evolving regulatory landscape at the FDA and what it means for life sciences leaders. This episode covers: Staff changes to the FDA and approval pathway pilot programs Rising scrutiny on trial design — especially in rare disease The FDA’s firmer stance on compounded GLP-1s as shortages ease From regulatory unpredictability to access, pricing, and portfolio risk, we explore how life sciences leaders s

As 2026 begins, pharma leaders are placing sharper bets earlier while navigating increasing pressure across pricing, access, and evidence. In this episode, Matt Riordan, Group President, Putnam, shares a candid, executive-level view of what leaders are prioritizing this year, where confidence is high, and where blind spots may limit impact. Drawing on real-world leadership conversations, the discussion explores how access and evidence expectations are shifting upstream and what it takes to press

As we kick off 2026, Mindy sits down with Inizio Ignite Global President, Remco op den Kelder, to discuss the industry forces shaping the year ahead for life sciences companies. Panel – Mindy McGrath, Remco op den Kelder Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

The rules of product launch are changing fast. Policy reform, payer pressure, AI adoption, and shifting system dynamics are redefining how life sciences companies prepare for market. In this episode, Summer Atkinson sits down with Vynamic Health Industry Advisor Mindy McGrath to unpack the biggest forces impacting launches today—from accelerating decision-making to growing health system control—and how leading organizations are building agility, transparency, and value-driven strategies to stay